24 results
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
risks resulting from the outbreak of the coronavirus (COVID-19) or from another pandemic, epidemic or outbreak of an infectious disease, any of which … in the future by a pandemic, epidemic or outbreak of an infectious disease like the outbreak of COVID-19. For example, as a result of measures imposed
424B4
MAIA
MAIA Biotechnology Inc
25 Apr 23
Prospectus supplement with pricing info
7:45pm
) or from another pandemic, epidemic or outbreak of an infectious disease, any of which could have a material adverse effect on our business … .
The development of our drug candidates could be disrupted and materially adversely affected in the future by a pandemic, epidemic or outbreak of an infectious
DRS
13m7h
23 Dec 22
Draft registration statement
12:00am
10-Q
3pctf1rp6yg
22 Aug 22
Quarterly report
8:44am
8-K
EX-99.2
05i 29ounq119h6ywcn
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
8-K
EX-99.1
1uhq8nr1bheb wj
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
424B4
76ob6u wm3rc
29 Jul 22
Prospectus supplement with pricing info
8:31am